Introduction
============

Sampling for evaluation of hematological and biochemical analytes is a useful, nonlethal, and minimally invasive method to determine health status of the individual bird and avian populations.[@b1-vmrr-6-061]--[@b8-vmrr-6-061] However, venipuncture and blood sample collection from Passeriformes is often hindered by patient size and temperament as well as clinical skill of the sample collector. Furthermore, the effect of capture and handling stress on various blood analytes is difficult to control and account for in field studies.[@b9-vmrr-6-061] Midazolam is a short-acting benzodiazepine with potent anxiolytic, amnestic, hypnotic, anticonvulsant, muscle relaxant, and sedative properties, convenient for use in animals based on a short elimination half-life, water solubility allowing multiple administration options, rapid onset of action, reversibility, and minimal cardiovascular effects.[@b10-vmrr-6-061]--[@b12-vmrr-6-061] Midazolam has been administered intranasally to sedate parrots, canaries *Serinus canarius*, finches *Taeniopygia guttata*, and other avian species for research and clinical case management.[@b11-vmrr-6-061]--[@b16-vmrr-6-061] Sedation with midazolam in birds decreases vocalization, flight, and defense responses, and facilitates handling for diagnostic and minor therapeutic procedures.[@b11-vmrr-6-061],[@b12-vmrr-6-061],[@b17-vmrr-6-061],[@b18-vmrr-6-061] Additional study of midazolam has been recommended for "reducing stress in captured wild birds".[@b14-vmrr-6-061]

The objective of this prospective cross-sectional study was to assess feasibility and safety of the sedative midazolam administered intranasally to Passeriformes in a field setting. Midazolam was hypothesized to be an easily administered, rapid-onset, effective, and safe sedative for Passeriformes to facilitate handling and sample collection. Midazolam's effect on select venous blood analytes was also assessed by comparing those obtained in this study to a study that assessed Passeriforme health in nonsedated birds.[@b19-vmrr-6-061] Some nonspecific measures of stress such as lactate or glucose concentrations were also hypothesized to differ based on administration of midazolam. These findings are the first large-scale assessment of midazolam sedation in free-living Passeriformes and the first report of the effect of midazolam on venous blood analytes in these species.

Materials and methods
=====================

Specimen collection
-------------------

In conjunction with an ongoing specimen collection for assessment of avian genetic variation and biodiversity in Texas, 104 Passeriformes were sampled from March to June 2012 from eight counties of Texas (Bastrop, Caldwell, Comal, Grimes, Hays, Kerr, Travis, Williamson). Coordinates of sampling spanned 29.47.686--30.55.011 N latitude and 96.05.604--99.23.731 W longitude. Time of day for sampling ranged from 7.30 am to 12.45 pm central standard time. Season, region, time of day, and method of capture of birds were similar to a previous study in which sedation was not administered.[@b19-vmrr-6-061] Research was conducted under required Texas Parks and Wildlife and United States Fish and Wildlife Permits and with approval of the Texas A&M University Institutional Animal Care and Use Committee.

Animal sampling
---------------

Birds were captured via mist net and placed in cloth bags until administration of midazolam (5 mg/mL injection USP; Hospira, Inc., Lake Forest, IL, USA) intranasally at a dose of 5.55±2.66 (mean ± standard deviation \[SD\], range 2.39--13.5) mg/kg.[@b12-vmrr-6-061],[@b15-vmrr-6-061],[@b17-vmrr-6-061] Birds were initially dosed based on weights ([Table 1](#t1-vmrr-6-061){ref-type="table"}) generalized from known species weight ranges; exact dosages were later recalculated using postmortem frozen bird weight. Birds were then held in bags for at least 5 minutes to allow calming and sedation to occur before sampling. Sedation score was determined based on a modified sedation scale ([Table 2](#t2-vmrr-6-061){ref-type="table"}).[@b20-vmrr-6-061],[@b21-vmrr-6-061] Animals were manually restrained for collection of 0.2--0.5 mL of blood via jugular venipuncture with needle and syringe. Jugular venipuncture was chosen as a central nonlethal sampling option which allowed closed sampling for appropriate determination of venous blood gases and acid based status in the noncritical patient.[@b9-vmrr-6-061],[@b22-vmrr-6-061],[@b23-vmrr-6-061] Adverse or unusual events were recorded and records were reviewed for similar events in nonsedated birds from a previous study.[@b19-vmrr-6-061]

Sample analysis
---------------

Blood samples were collected with needle and syringe and then transferred to lithium heparin microtainer tubes (Sarstedt, IDEXX Laboratories, Westbrook, ME, USA); analyses occurred within 5 minutes of sample collection using the i-STAT^®^ system (Abbott Laboratories, Abbott Park, IL, USA). Blood gas cartridges (CG4+ or CG8+) were used first, followed by cartridges which did not analyze blood gases (6+, E3+, or E3+Cl). Time of day was recorded as time of analyte results for the first cartridge. Analytes determined were based on the cartridge and blood volume obtained and included: pH (venous), venous carbon dioxide partial pressure (pCO~2~), venous oxygen partial pressure (pO~2~), lactate, bicarbonate (HCO~3~), total carbon dioxide (TCO~2~), base excess (BE), venous dissolved oxygen (sO~2~), ionized calcium, glucose, blood urea nitrogen (BUN), calculated hematocrit (Hct), hemoglobin (Hgb), sodium (Na), potassium (K), and chloride (Cl). Most values obtained by the i-STAT^®^ system are measured directly, but TCO~2~, BE, Hgb and sO~2~, are calculated.[@b24-vmrr-6-061] Lithium heparin microhematocrit tubes (Statspin^®^ centrifuge; Iris^®^ sample processing, Westwood, MA, USA) were used to determine packed cell volume (PCV) and were centrifuged at 15,000 *g* for 3 minutes within 24 hours of blood collection. After venipuncture, a physical examination was performed. Birds were then humanely killed via thoracic compression and frozen until preparation as standard museum specimens that are deposited at the Biodiversity Research and Teaching Collections at Texas A&M University. Species, sex, and age were determined based on external field markings and confirmed during specimen preparation. Body weight was determined at specimen preparation.

Additional calculations
-----------------------

Temperature corrections with an assumed Passeriforme core body temperature of 41.3°C were performed for pH, pCO~2~, and pO~2~ as follows:[@b9-vmrr-6-061],[@b24-vmrr-6-061] $$T_{41.3{^\circ}C}\text{pO}_{2} = (\text{pO}_{2})\left\lbrack 10^{\frac{(5.49 \times 10^{- 11} \times {(\text{pO}_{2})}^{3.88} + 0.071)}{(9.72 \times 10^{- 9}) \times {(\text{pO}2)}^{3.88} + 2.30)}(4.3)} \right\rbrack$$ $$\begin{array}{l}
{T_{41.3{^\circ}C}\text{pH} = \text{pH} - 0.0147(4.3)} \\
{\qquad + 0.0065(7.4 - \text{pH})(4.3)} \\
\end{array}$$ $$T_{41.3{^\circ}C}\text{pCO}_{2} = \text{pCO}_{2}\lbrack 10^{(0.0817)}\rbrack$$

Anion gap was calculated for the median analyte values of birds treated and not treated with midazolam via the formula: $$\text{Anion~gap} = \left( {\text{Na} + K} \right) - \left( {\text{Cl} + \text{HCO}_{3}} \right)$$

For comparison to Hgb values determined by the iSTAT-1^®^, Hgb was calculated via the passerine formula:[@b25-vmrr-6-061] $$\text{Hgb} = \left( 0.33 \right)\left( \text{PCV} \right) + 0.011$$

Statistical methods
-------------------

Initial data analyses were performed with the statistical software Analyse-it^®^ (Analyse-it Software, Ltd., Leeds, UK) for Microsoft Excel (Version 2.20 Microsoft Office v 2010; Microsoft Corporation, Redmond, WA, USA). To assess the effect of midazolam on blood analytes, analyte values of Passeriformes receiving midazolam were compared with those obtained from the same species of passerines collected in the previous years which did not receive midazolam.[@b19-vmrr-6-061] Species were grouped for comparison of values via Kruskal--Wallis one-way analysis of variance when species numbers were greater than two and had at least one bird in the sedated and nonsedated categories ([Table 3](#t3-vmrr-6-061){ref-type="table"}). Analysis of variance was used to assess the effect of midazolam dose (mg/kg) on bird sedation score. Kruskal--Wallis one-way analysis of variance assessed the effect of Hct on BUN. A Bland--Altman plot was used to determine the agreement of Hct and PCV for all samples. Additional statistical analysis was performed with R for mixed modeling.[@b26-vmrr-6-061] The effect of selected variables on iSTAT-1 values was assessed using a linear mixed model with iSTAT-1 values as outcome variables; age, sex, midazolam sedation (1 or 0), and interactions as fixed effects; and species as random effect. Residual plots were used to assess linearity, homogeneity of variances, normality, and outliers. A type III analysis of variance was performed on the fixed effects and post hoc comparisons were performed using a Tukey adjustment. When necessary to meet assumptions of the linear mixed models, log transformation of the outcome variables was used. When assumptions of the linear models could not be met, a two-sample Wilcoxon test was performed on the iSTAT-1 values to assess the effect of midazolam sedation, sex, and age separately. Alpha of 0.05 was used for significance for all statistical outcomes.

Results
=======

One hundred and four birds were captured and sedated from a variety of Passeriformes, mostly of the Paridae family ([Table 3](#t3-vmrr-6-061){ref-type="table"}). Midazolam doses administered averaged 5.6±2.7 mg/kg. Notable side effects were regurgitation in two birds and egg production in three birds after administration of midazolam; these clinical signs were not noted in the previous field season. A single bird, excluded from the figure, received 2.79 mg/kg midazolam and was given a sedation score of 2 but died during sampling. Sedation scores increased as midazolam dose increased ([Figure 1](#f1-vmrr-6-061){ref-type="fig"}). To assess the effect of midazolam on multiple blood analytes, we compared analytes of blood samples from 95 Passeriformes which had midazolam administered to those obtained from 96 birds which were not administered midazolam ([Table 3](#t3-vmrr-6-061){ref-type="table"}). Electrolyte concentrations and venous blood gas analytes were affected by midazolam sedation although hematological values (PCV, Hgb, Hct) and pH were not ([Tables 3](#t3-vmrr-6-061){ref-type="table"}[](#t4-vmrr-6-061){ref-type="table"}--[5](#t5-vmrr-6-061){ref-type="table"}). The midazolam-treated group had lower pO~2~ and sO~2~ while pCO~2~, TCO~2~, and HCO~3~ were higher in birds receiving midazolam. Modeling of multiple variables (species, age, sex, and midazolam administration) found that some variability occurred based on species for all analytes ([Table 5](#t5-vmrr-6-061){ref-type="table"}). However, blood gases and acid--base analytes appeared least affected by species (\<27%). Age affected BE and HCO~3~ while the effect of sex was limited to glucose, Hct, and Hgb. Most BUN values were below the limit of detection (2 mg/dL) for the analyzer (n=95); reported BUN values (n=12) were nonparametrically distributed (Shapiro--Wilk *P*\<0.0001). Detection of BUN was not affected by Hct (Kruskal--Wallis *P*=0.5923) midazolam administration did not have effect on detection or detected concentrations of BUN. (Kruskal--Wallis *P*=0.2833) (n=60, median 5.0, 95% confidence interval 4.5--7.6 mg/dL). PCV as determined by centrifugation and Hct as reported by the iSTAT-1 had poor agreement ([Figure 2](#f2-vmrr-6-061){ref-type="fig"}). Hgb as determined by the iSTAT-1 and via calculation from PCV had poor agreement ([Figure 3](#f3-vmrr-6-061){ref-type="fig"}). Temperature correction of median values for venous blood pH (pH~T41.3~ =7.507), pO~2~, and pCO~2~ in groups treated and not treated with midazolam caused no clinically significant changes. Temperature correction of median pO~2~ venous blood values of birds receiving and not receiving midazolam, respectively, were 46.11 and 51.51 mmHg. Temperature correction of pCO~2~ resulted in median pCO~2T41.3~ with and without midazolam equalling 31.74 and 37.18 mmHg, respectively. Median anion gap calculated for groups administered and not administered midazolam also failed to reveal a clinically significant difference at 14.4 and 13.1, respectively.

Discussion
==========

Sedation
--------

Based on adequate sedation for most birds in this study and the death of only a single bird, midazolam appears safe and efficacious with a wide margin of safety for short-term field sedation in Passeriformes. Intranasal administration was chosen based on a previous study that found that this route was easy and offered high bioavailability, rapid onset of action, reduced pain compared to intramuscular administration, and reduced likelihood of neuromuscular damage in these very small species.[@b15-vmrr-6-061] In addition, intranasal administration requires minimal training or equipment and is rapid and inexpensive.[@b27-vmrr-6-061] However, full recovery and release of birds was not a goal of this study. Further study of midazolam reversal and monitoring prior to release as well as long term effects of this sedative drug on free-living avian species are recommended. This study was similar to a previous trial which found an increased risk of regurgitation with use of this drug, as this side effect was restricted to treated birds.[@b27-vmrr-6-061] Body temperature, respiratory rate, and duration of recumbency were not assessed in this study, based on the difficulty of these assessments in field conditions and on small free-flighted subjects, but are recommended for future assessments of midazolam in birds.[@b15-vmrr-6-061],[@b27-vmrr-6-061]

The dose range chosen was similar to those previously administered intranasally in other small, captive bird species such as budgerigars, finches, and canaries.[@b14-vmrr-6-061],[@b17-vmrr-6-061],[@b28-vmrr-6-061] As expected, sedation increased based on increasing doses of midazolam. However, our calculated dose range extended to above that previously reported without causing apparent immediate harm in birds given higher doses, and many birds (n=14) were unacceptably sedated using doses at or above the previously recommended ranges.[@b12-vmrr-6-061],[@b14-vmrr-6-061],[@b15-vmrr-6-061],[@b18-vmrr-6-061] Our study supports the concept that a wide therapeutic window exists in Passeriformes, as in other species, and that the standard lower dose used on larger birds may not provide sufficient sedation in some small birds. Similarly, in the short-term, a higher dose may be safe for sedation. However species effect on sedation level, if any, was not assessed or determined based on small sample sizes.

Analytes
--------

In contrast to a single previous study of the effect of midazolam on biochemical values in birds, multiple biochemical values varied based on midazolam administration in this study.[@b11-vmrr-6-061] Glucose concentrations were higher in samples obtained from birds administered midazolam than those that were not. A sex-related effect was also further confirmed in this study as found previously.[@b19-vmrr-6-061] Mechanisms for the relative hyperglycemia in male birds and birds receiving midazolam are unclear. However, estrogens, other hormones, and sedation can affect glucose levels possibly to the significant, although nonclinically relevant, extent observed.[@b29-vmrr-6-061] Reduced struggling of the sedated bird could have lessened peripheral glucose use and metabolism of glycogen stores, resulting in increased blood glucose concentrations.

Despite low sample size, decreased BUN concentration and decreased likelihood of detecting BUN in birds receiving midazolam based on linear modeling suggests that this analyte deserves further investigation as a health indicator of Passeriformes. In birds, BUN is not the primary product of nitrogen metabolism but BUN concentration may increase with dehydration.[@b8-vmrr-6-061] However, clinical-study notes failed to reveal clinical signs of dehydration or hemoconcentration in those birds with detectable BUN.

Increased potassium in the group untreated with midazolam could be attributable to increased hemolysis, rhabdomyolysis, or other exertional trauma in the group not receiving sedation.[@b9-vmrr-6-061],[@b11-vmrr-6-061] Certainly, capture myopathy has been reported in multiple avian species; Passeriformes may also be susceptible.[@b30-vmrr-6-061]--[@b32-vmrr-6-061] Dietary intake was considered an unlikely cause of this difference based on species grouping and similar times of year of sampling. Hemolysis was not assessed in this study. Intracellular concentrations of potassium in the Passeriforme erythrocyte have not been evaluated and would be an important consideration for future studies. While a variety of diseases have been associated with increased potassium concentrations, all birds sampled appeared healthy based on physical examination at the time of sampling. The lower chloride in the group administered midazolam was statistically significant but a relatively minor clinical change; no sodium change was associated with this finding. Regurgitation, egg production, and other fluid loss may have resulted based on centrally mediated muscular relaxation of midazolam in this group, resulting in lower sodium. In Passeriformes administered midazolam, one must account for expected changes in electrolyte concentrations if these analytes are under scrutiny to assess population or ecosystem health.

Lactate concentrations were lower in birds receiving midazolam, suggesting that increased exertion occurred in birds not receiving midazolam. Anxiolysis, sedation, hypnosis, or the centrally mediated muscle relaxant effects of midazolam likely mediated this result. The similar pH and anion gap of the treated and untreated groups suggests that neither midazolam nor handling without midazolam creates life-threatening uncompensated acid--base imbalance. Thus, while midazolam is safe, it is not necessary unless complicated capture or sampling is anticipated.[@b9-vmrr-6-061],[@b11-vmrr-6-061] Increased venous concentrations of HCO~3~ in birds treated with midazolam provides further evidence of acid--base compensation. Hypoventilation in these birds likely resulted in increased relative CO~2~ concentrations; bicarbonate is then increased to normalize pH; thus, a relative increase in base excess in the treated group likely occurred based on compensatory relative metabolic alkalosis.

pCO~2~ was higher, and sO~2~% and pO~2~ were lower, in birds administered midazolam suggesting a state of a relative hypoventilation in birds receiving this drug. These analytes were among those least affected by species, age, or sex. Hypotension and respiratory depression are common side effects of this drug in humans and may have occurred in the Passeriformes studied. Decreased respiratory rate has been reported after administration of this drug to avian species.[@b15-vmrr-6-061],[@b27-vmrr-6-061] Future studies should evaluate respiratory rate, cardiac output, and perfusion; however, some of these parameters are challenging to evaluate in a field setting.

Regardless of midazolam administration, birds maintained a relatively basic blood pH; temperature correction did not result in clinically relevant change in this value (pHT41.3 =7.507). Temperature correction of blood gas analytes were consistent with birds having a higher venous pO~2~ and pCO~2~ than humans which is similar to findings in other avian arterial blood gases.[@b9-vmrr-6-061],[@b33-vmrr-6-061]--[@b36-vmrr-6-061] An attenuated increase in body temperature has been reported in parrots after administration of midazolam; thus, parameters subject to temperature correction might be expected to change less in birds given midazolam based on the moderated temperature in treated birds.[@b15-vmrr-6-061] However, cloacal temperature was not measured in treated or untreated birds based on the lack of technical feasibility.

No differences were noted for the erythrocyte para meters (PCV, Hct, Hgb) of birds that did and did not receive midazolam. Linear mixed modeling further supported that sex but not age or midazolam administration affected Hct and Hgb. PCV agreed poorly with Hct, as previously published.[@b19-vmrr-6-061] Values for Hct averaged 14.8% lower on the iSTAT-1^®^ system than that provided via centrifugal determination of PCV. This difference is likely based on different analysis methods; the shape, size, and density of avian blood cells; and increased glucose concentrations and the lower total protein of avian blood.[@b24-vmrr-6-061],[@b37-vmrr-6-061] The iSTAT-1 system is not recommended as a sole determinant of Hgb or Hct in birds as results do not agree clinically with the gold standard PCV. Use of a single correction factor for all avian species appears inappropriate based on findings in this study and other previously published data.[@b19-vmrr-6-061],[@b35-vmrr-6-061],[@b38-vmrr-6-061]

The iSTAT-1 system calculates Hgb (g/dL) as hematocrit (% PCV) ×0.34.[@b24-vmrr-6-061] This calculation, which differs from that validated for Passeriformes, and the erroneous PCV determination make it highly unlikely that Hgb determined by the iSTAT-1 is accurate. We report results here only for completeness and recommend that future studies address the validity of this unit for determination of Hgb in birds.

Conclusion
==========

Midazolam is efficacious and has a broad therapeutic safety margin for short-term sedation of free-living Passeriformes. However, the recovery period requires more study before we can recommend this sedative for field use in birds destined for release. Hematological variables (Hct, PCV, Hgb) were minimally affected by administration of midazolam. However, multiple blood gas parameters, electrolyte concentrations, and biochemical blood analytes were affected by administration of midazolam and should be taken into consideration if used to assess avian population health. Changes in glucose, potassium, and lactate concentrations support the hypothesis that midazolam lessens the stress of free-living birds undergoing capture. However, blood gas values suggest that birds administered midazolam suffer relative hypoventilation. Further assessment of midazolam for field use, as well as the companion reversal drug flumazenil to facilitate assessment of Passeriforme population and therefore ecosystem health, is recommended.
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![Sedation of 102 free-living Passeriformes with intranasal midazolam.\
**Notes:** Box and whisker plot of the midazolam dose range (top and bottom whiskers), median line, mean, and the 1st and 3rd quartiles within each sedation score. Sedation of Passeriformes based on midazolam dose was significantly different between groups.\
**Abbreviation:** ANOVA, analysis of variance.](vmrr-6-061Fig1){#f1-vmrr-6-061}

![Bland--Altman plot of poor agreement between PCV and Hct in Passeriformes.\
**Notes:** Hct as determined by the i-STAT-1 and PCV as determined by centrifugation of 78 apparently healthy free-living Passeriformes administered midazolam. High bias and multiple results outside the limits of agreement suggest that Hct values are clinically unacceptable without the use of a correction factor. Means of these two groups were also significantly different based on Student's *t*-test (*P*\<0.0001).\
**Abbreviations:** Hct, iSTAT-1 calculated hematocrit; PCV, packed cell volume.](vmrr-6-061Fig2){#f2-vmrr-6-061}

![Comparison of two methods of hemoglobin determination from 156 free-living Passeriformes.\
**Notes:** Bland--Altman plot comparison of hemoglobin calculated from PCV with published methods and as determined by the iSTAT-1. Multiple outliers, 3.91 g/dL bias, as well as Student's *t*-test (*P*\<0.0001) suggest that these results are clinically incompatible.\
**Abbreviations:** Hgb, hemoglobin; PCV, packed cell volume.](vmrr-6-061Fig3){#f3-vmrr-6-061}

###### 

Midazolam (5 mg/mL solution) dosing for field sedation of Passeriformes

  Midazolam volume (mL)   Approximate weight (g)   Passeriformes
  ----------------------- ------------------------ ----------------------------------------------
  0.01                    10--20                   Chickadee, titmice, warbler, vireo, sparrow
  0.02                    30--50                   Cardinal, woodpecker, mockingbird, inca dove
  0.03                    \~80                     Jay, white-winged dove, mourning dove

###### 

Modified sedation scale and clinical effect of midazolam on free-living Passeriformes

  Score   Effect           Clinical observations                                                              n
  ------- ---------------- ---------------------------------------------------------------------------------- ----
  1       None             No apparent effect; bright, alert, and responsive                                  15
  2       Light sedation   Less responsive until handled, some struggling                                     56
  3       Good sedation    Relaxed but alert, righting reflex present but delayed, animal easily handled      28
  4       Heavy sedation   Minimally responsive, animal does not struggle, only withdrawal reflexes present   6
  5       Death            Died after midazolam administered, prior to euthanasia                             1

###### 

Midazolam treated and untreated Passeriformes sampled for iSTAT-1 values

  Common name                   Scientific name                  Midazolam (n)   No midazolam (n)
  ----------------------------- -------------------------------- --------------- ------------------
  Acadian flycatcher            *Empidonax virescens*            1               0
  Black-and-white warbler       *Mniotilta varia*                4               0
  **Bewick's wren**             ***Thryomanes bewickii***        **4**           **7**
  **Black-crested titmouse**    ***Baeolophus atricristatus***   **13**          **14**
  Blue-gray gnatcatcher         *Polioptila caerulea*            2               *0*
  **Carolina chickadee**        ***Poecile carolinensis***       **9**           **8**
  **Carolina wren**             ***Thryothorus ludovicianus***   **7**           **18**
  **Eastern phoebe**            ***Sayornis phoebe***            **5**           **2**
  **Hermit thrush**             ***Catharus guttatus***          **4**           **1**
  Hooded oriole                 *Icterus cucullatus*             1               0
  Lark sparrow                  *Chondestes grammacus*           3               0
  Nashville warbler             *Oreothlypis ruficapilla*        2               0
  **Northern cardinal**         ***Cardinalis cardinalis***      **10**          **5**
  **Northern mockingbird**      ***Mimus polyglottos***          **2**           **1**
  **Orange-crowned warbler**    ***Oreothlypis celata***         **3**           **5**
  **Painted bunting**           ***Passerina ciris***            **9**           **3**
  **Rufous-crowned sparrow**    ***Aimophila ruficeps***         **3**           **5**
  **Summer tanager**            ***Piranga rubra***              **2**           **2**
  **Tufted titmouse western**   ***Baeolophus bicolor***         **13**          **17**
  **White-eyed vireo**          ***Vireo griseus***              **8**           **8**
  Total                                                          104             96

**Note:** Species selected for comparison of analytes are in bold.

###### 

Effect of midazolam on iSTAT-1 values for venous blood of Passeriformes

  Treatment                                            Midazolam   No midazolam                                                                                             
  ---------------------------------------------------- ----------- -------------- ------ ------ ---- --------------------------------------------------- ------ ------ ---- ----------
  Base excess                                          mmol/L      6              2.7    9.0    77   3.0                                                 −1.0   6.0    80   0.0002
  BUN[\*\*](#tfn2-vmrr-6-061){ref-type="table-fn"}     mmol/L      2              2      2      7    2                                                   2      3      17   0.2833
  Chloride                                             mmol/L      119            117    122    73   124                                                 120    126    55   \<0.0001
  Glucose                                              mmol/L      364            231    393    75   327                                                 282    384    75   0.0118
  HCO~3~                                               mmol/L      28             25     30.4   77   24.1                                                21.4   27.0   80   \<0.0001
  Hct                                                  \%          42             39     45     75   42                                                  39     45     81   0.6956
  Hgb                                                  g/dL        14.3           13.3   15.3   75   14.3                                                13.3   15.3   81   0.7301
  Potassium                                            mmol/L      3.4            3.1    4.0    73   4.2[\*\*](#tfn2-vmrr-6-061){ref-type="table-fn"}    3.5    4.7    80   \<0.0001
  Lactate                                              mmol/L      2.79           2.35   3.13   78   4.39[\*\*](#tfn2-vmrr-6-061){ref-type="table-fn"}   3.50   5.45   53   \<0.0001
  pCO~2~                                               mmHg        30.8           26.1   33.9   80   26.3                                                23.0   29.2   80   \<0.0001
  PCV                                                  \%          54             50     60     63   55[\*\*](#tfn2-vmrr-6-061){ref-type="table-fn"}     52.4   60     92   0.1403
  pH at 37°C                                                       7.57           7.52   7.61   77   7.58[\*\*](#tfn2-vmrr-6-061){ref-type="table-fn"}   7.54   7.63   80   0.3307
  pO~2~[\*\*](#tfn2-vmrr-6-061){ref-type="table-fn"}   mmHg        34             31     38     78   38.0                                                34.0   40.0   80   0.0008
  sO~2~                                                \%          77             71     82     77   81                                                  76     85     80   0.0012
  Sodium                                               mmol/L      158            156    161    75   157                                                 153    160    81   0.0368
  TCO~2~                                               mmol/L      29             26     31     77   25                                                  22     28.6   80   \<0.0001
  Total                                                                                         94                                                                     92   

**Notes:**

Shapiro--Wilk *P*-value for normality \>0.05 nonnormal; KW significant *P*\<0.05.

**Abbreviations:** BUN, blood urea nitrogen; Hct, iSTAT-1 calculated hematocrit; Hgb, hemoglobin; KW, Kruskal--Wallis; pCO~2~, venous carbon dioxide partial pressure; PCV, packed cell volume; pO~2~, venous oxygen partial pressure; Q1, 1st quartile; Q3, 3rd quartile; sO~2~, venous dissolved oxygen; TCO~2~, total carbon dioxide.

###### 

Mean difference of iSTAT-1 parameters based on sex, age, and midazolam sedation

  Treatment                                           Sex      *P*     Age                                               *P*     Midazolam                                         *P*     Species component of total variability               
  --------------------------------------------------- -------- ------- ------------------------------------------------- ------- ------------------------------------------------- ------- ---------------------------------------------------- -----
  BE                                                  mmol/L   0.9     0.23                                              2.0     0.03[\*](#tfn4-vmrr-6-061){ref-type="table-fn"}   −2.9    \<0.001[\*](#tfn4-vmrr-6-061){ref-type="table-fn"}   11%
  BUN                                                 mmol/L   0       0.59                                              0       0.98                                              0.5     0.01[\*\*](#tfn5-vmrr-6-061){ref-type="table-fn"}    NA
  Chloride                                            mmol/L   −0.8    0.29                                              −0.8    0.44                                              4.2     \<0.001[\*](#tfn4-vmrr-6-061){ref-type="table-fn"}   35%
  Glucose                                             mmol/L   28.7    0.01[\*](#tfn4-vmrr-6-061){ref-type="table-fn"}   −16.6   0.23                                              −31.3   0.059[\*](#tfn4-vmrr-6-061){ref-type="table-fn"}     31%
  HCO~3~                                              mmol/L   0.9     0.16                                              1.6     0.05[\*](#tfn4-vmrr-6-061){ref-type="table-fn"}   −3.1    \<0.001[\*](#tfn4-vmrr-6-061){ref-type="table-fn"}   16%
  Hgb                                                 g/dL     −0.57   0.02[\*](#tfn4-vmrr-6-061){ref-type="table-fn"}   0.38    0.19                                              0.27    0.28                                                 23%
  Hct                                                 \%       −1.7    0.02[\*](#tfn4-vmrr-6-061){ref-type="table-fn"}   1.1     0.21                                              0.8     0.26                                                 23%
  Potassium                                           mmol/L   −0.1    0.22                                              0.0     0.87                                              0.5     \<0.001[\*](#tfn4-vmrr-6-061){ref-type="table-fn"}   34%
  Lactate[†](#tfn6-vmrr-6-061){ref-type="table-fn"}   mmol/L   0.99    0.71                                              1.04    0.50                                              1.57    \<0.001[\*](#tfn4-vmrr-6-061){ref-type="table-fn"}   43%
  pCO~2~                                              mmHg     0.74    0.38                                              0.34    0.74                                              −4.05   \<0.001[\*](#tfn4-vmrr-6-061){ref-type="table-fn"}   16%
  PCV                                                 \%       0       0.39                                              −2      0.37                                              1       0.14[\*\*](#tfn5-vmrr-6-061){ref-type="table-fn"}    NA
  pH at 37°C                                                   0.00    0.94                                              0.03    0.06                                              0.00    0.58                                                 0%
  pO~2~[†](#tfn6-vmrr-6-061){ref-type="table-fn"}     mmHg     0.98    0.46                                              1.03    0.26                                              1.08    0.001[\*](#tfn4-vmrr-6-061){ref-type="table-fn"}     26%
  sO~2~                                               \%       −0.5    0.69                                              2.8     0.11                                              4.9     \<0.001[\*](#tfn4-vmrr-6-061){ref-type="table-fn"}   26%
  Sodium[†](#tfn6-vmrr-6-061){ref-type="table-fn"}    mmol/L   −1.1    0.12                                              −1.3    0.13                                              −2.0    0.008[\*](#tfn4-vmrr-6-061){ref-type="table-fn"}     34%
  TCO~2~                                              mmol/L   0.9     0.17                                              1.7     0.052                                             −3.1    \<0.001[\*](#tfn4-vmrr-6-061){ref-type="table-fn"}   16%

**Notes:**

Significant difference controlling for the other variables, fixed effects of linear mixed model. All interactions were nonsignificant;

Wilcoxon test *P*-values, differences are shown for the median.

Log transformation.

**Abbreviations:** BE, base excess; BUN, blood urea nitrogen; Hct, iSTAT-1 calculated hematocrit; Hgb, hemoglobin; NA, not applicable; pCO~2~, venous carbon dioxide partial pressure; PCV, packed cell volume; pO~2~, venous oxygen partial pressure; sO~2~, venous dissolved oxygen; TCO~2~, total carbon dioxide.
